These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31282256)

  • 1. The Global call for action on infection prevention and control.
    Avortri GS; Nabyonga-Orem J
    Int J Health Care Qual Assur; 2019 Jul; 32(6):927-940. PubMed ID: 31282256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the infection prevention and control core components at the national level: a global situational analysis.
    Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B
    J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline evaluation of the World Health Organization (WHO) infection prevention and control (IPC) core components in Pacific Island Countries and Territories (PICTs).
    Leong M; Picton R; Wratten M; Mahe A; Zimmerman PA
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):108. PubMed ID: 39334478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries.
    Alp E; Damani N
    J Infect Dev Ctries; 2015 Oct; 9(10):1040-5. PubMed ID: 26517477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study.
    Wood R; Tembele W; Hema A; Somé A; Kinganda-Lusamaki E; Basilubo C; Lumembe R; Alama N; Mbunsu G; Zongo A; Ahuka S; Muyembe JJ; Leendertz F; Eckmanns T; Schubert G; Kagoné T; Makiala S; Tomczyk S
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):4. PubMed ID: 38221629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of World Health Organization Guidelines in the Prevention of Surgical Site Infection in Low- and Middle-Income Countries:What We Know and Do Not Know.
    Rasa K; Kilpatrick C
    Surg Infect (Larchmt); 2020 Sep; 21(7):592-598. PubMed ID: 32478641
    [No Abstract]   [Full Text] [Related]  

  • 7. Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level.
    Tomczyk S; Aghdassi S; Storr J; Hansen S; Stewardson AJ; Bischoff P; Gastmeier P; Allegranzi B
    J Hosp Infect; 2020 May; 105(1):83-90. PubMed ID: 31870887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)-based survey.
    Azak E; Sertcelik A; Ersoz G; Celebi G; Eser F; Batirel A; Cag Y; Ture Z; Ozturk Engin D; Yetkin MA; Kaygusuz S; Candevir A; Tartari E; Rello J; Alp E;
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):11. PubMed ID: 36782267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).
    Zingg W; Storr J; Park BJ; Ahmad R; Tarrant C; Castro-Sanchez E; Tomczyk S; Kilpatrick C; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():87. PubMed ID: 31161034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first WHO global survey on infection prevention and control in health-care facilities.
    Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B
    Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection prevention and control (IPC) implementation in low-resource settings: a qualitative analysis.
    Tomczyk S; Storr J; Kilpatrick C; Allegranzi B
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):113. PubMed ID: 34332622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of infection prevention and control in acute care hospitals in Mainland China - a systematic review.
    Wang J; Liu F; Tan JBX; Harbarth S; Pittet D; Zingg W
    Antimicrob Resist Infect Control; 2019; 8():32. PubMed ID: 30792854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 17th International Congress on Infectious Diseases workshop on developing infection prevention and control resources for low- and middle-income countries.
    Sastry S; Masroor N; Bearman G; Hajjeh R; Holmes A; Memish Z; Lassmann B; Pittet D; Macnab F; Kamau R; Wesangula E; Pokharel P; Brown P; Daily F; Amer F; Torres J; O'Ryan M; Gunturu R; Bulabula A; Mehtar S
    Int J Infect Dis; 2017 Apr; 57():138-143. PubMed ID: 28216179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Aghdassi SJS; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2019; 8():73. PubMed ID: 31080588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study of infection prevention and control practices in the maternal units of two Ghanaian hospitals.
    Sunkwa-Mills G; Senah K; Breinholdt M; Aberese-Ako M; Tersbøl BP
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):125. PubMed ID: 37953285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3).
    Zingg W; Storr J; Park BJ; Jernigan JA; Harbarth S; Grayson ML; Tacconelli E; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():74. PubMed ID: 31168366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of infection prevention and control committees in Lesotho: A qualitative study.
    Mugomeri E
    Am J Infect Control; 2018 Mar; 46(3):e13-e17. PubMed ID: 29326003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection prevention and control strategies in the era of limited resources and quality improvement: a perspective paper.
    Vandijck D; Cleemput I; Hellings J; Vogelaers D
    Aust Crit Care; 2013 Nov; 26(4):154-7. PubMed ID: 23969192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of infection prevention and control programmes according to the European Centre for Disease Prevention and Control and the World Health Organization in Spain 2012-2022: indicators of core component 1.
    Parra LM; Cantero M; Ortí-Lucas RM; Salcedo-Leal I; Asensio Á;
    J Hosp Infect; 2024 May; 147():17-24. PubMed ID: 38432588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework.
    Aghdassi SJS; Grisold A; Wechsler-Fördös A; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):92. PubMed ID: 32571434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.